RxDoctor Payments Data

Emilee Bocker, MD

Family Medicine · Amboy, ILNPI 1265726327

Payments from drug & device makers

$365in general payments, 2019–2025

Across 24 payments — averaging $15.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$91
  • Pfizer$60
  • AstraZeneca$36
  • Merck$31
  • E.r. Squibb & Sons, L.L.C.$28
  • Mylan Specialty L.p.$28
  • plus $93 from 5 others

What the payments were for

  • Food & beverage$365100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$365 in reported general payments places this provider in the 60th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$84,535
Medicare patients
367
Services billed
1,099

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide85$101,104
EliquisApixaban92$88,807
JanuviaSitagliptin Phosphate25$39,596
JardianceEmpagliflozin18$30,735
Tresiba Flextouch U-100Insulin Degludec31$22,057
MyrbetriqMirabegron27$19,516
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$18,230
Praluent PenAlirocumab23$13,708
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr20$9,211
EntrestoSacubitril/Valsartan13$8,329
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$8,111
Emgality SyringeGalcanezumab-Gnlm11$8,094
Repatha SureclickEvolocumab13$7,428
MovantikNaloxegol Oxalate13$7,133
SymbicortBudesonide/Formoterol Fumarate13$7,048

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$91$101,10485 claims
PfizerEliquis, Paxlovid$60$90,277104 claims
MerckJanuvia$31$39,59625 claims
Boehringer IngelheimJardiance, Stiolto Respimat$15$38,84529 claims
AstraZenecaSymbicort$36$7,04813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Amboy

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →